Inaktiver Wert

Santarus, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	31.12.13
Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	30.12.13
Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	23.12.13
Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	11.11.13
The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	08.11.13

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	-4,66 %	86,13 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+1,32 %	39,82 Mrd.
BIOGEN INC.	-19,27 %	30,42 Mrd.
UCB	+57,86 %	25,23 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-16,09 %	15,36 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14 %	11,95 Mrd.
INCYTE CORPORATION	-17,69 %	11,6 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00 %	11,51 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+5,24 %	8,71 Mrd.